Sanofi India
Ticker > Company >

Sanofi India share price

Sanofi India Ltd.

NSE: SANOFI BSE: 500674 SECTOR: Pharmaceuticals & Drugs  116k   360   46

6054.65
+1.70 (0.03%)
BSE: 22 Nov 04:00 PM

Price Summary

Today's High

₹ 6130

Today's Low

₹ 6025

52 Week High

₹ 10526.05

52 Week Low

₹ 5850.55

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 13944.24 Cr.

Enterprise Value

₹ 13539.34 Cr.

No. of Shares

2.3 Cr.

P/E

32.83

P/B

18.18

Face Value

₹ 10

Div. Yield

2.75 %

Book Value (TTM)

₹  332.96

CASH

₹ 404.9 Cr.

DEBT

₹ 0 Cr.

Promoter Holding

60.4 %

EPS (TTM)

₹  184.41

Sales Growth

2.92%

ROE

55.83 %

ROCE

73.98%

Profit Growth

-2.8 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Sanofi India Ltd.

Allegra Avil Combiflam Clexane Cardace Daonil Lantus Taxotere Soframycin Arava Lasix

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year2.92%
3 Year-0.59%
5 Year0.57%

Profit Growth

1 Year-2.8%
3 Year8.09%
5 Year9.65%

ROE%

1 Year55.83%
3 Year45.74%
5 Year35.33%

ROCE %

1 Year73.98%
3 Year60.47%
5 Year47.39%

Debt/Equity

0

Price to Cash Flow

60.42

Interest Cover Ratio

498.5294

CFO/PAT (5 Yr. Avg.)

0.722777777777778

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 60.40 0.00
Jun 2024 60.40 0.00
Mar 2024 60.40 0.00
Dec 2023 60.40 0.00
Sep 2023 60.40 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company has been maintaining healthy ROE of 45.7366929788447% over the past 3 years.
  • Company has been maintaining healthy ROCE of 60.4722818915088% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 498.5294.
  • The Company has been maintaining an effective average operating margins of 24.4535181011816% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -16.4072 days.
  • The company has a high promoter holding of 60.4%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 16.5229653780737.

 Limitations

  • The company has shown a poor profit growth of 8.09335704992984% for the Past 3 years.
  • The company has shown a poor revenue growth of -0.586958413285532% for the Past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 490.7 693.9 732.4 463.5 524
Total Expenditure 377.2 506.5 513.5 347.8 404.3
Operating Profit 113.5 187.4 218.9 115.7 119.7
Other Income 10.6 12 6.5 4.8 2.3
Interest 0.3 0.4 0.3 0.4 0.4
Depreciation 9.2 10.2 10 9 9
Exceptional Items 0 0 -26.7 -19 0
Profit Before Tax 114.6 188.8 188.4 92.1 112.6
Tax 34 51.1 51.8 23.9 30.4
Profit After Tax 80.6 137.7 136.6 68.2 82.2
Adjusted EPS (Rs) 35.04 59.87 59.39 29.65 35.74

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023
Net Sales 3070.6 2901.9 2956.6 2770.1 2851.1
Total Expenditure 2405.3 2188.8 2194.3 2067.2 2048.3
Operating Profit 665.3 713.1 762.3 702.9 802.8
Other Income 94.1 89.8 74.6 73 66.5
Interest 0.3 1.8 1.8 1.7 1.7
Depreciation 99.9 82.2 66.7 41.9 39.6
Exceptional Items -59.3 -41.7 489.2 132 17.8
Profit Before Tax 599.9 677.2 1257.6 864.3 845.8
Tax 185.7 199.6 313.2 243.7 242.6
Net Profit 414.2 477.6 944.4 620.6 603.2
Adjusted EPS (Rs.) 180.09 207.65 410.61 269.83 262.26

Balance Sheet (All Figures are in Crores.)

Particulars Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023
Equity and Liabilities
Share Capital 23 23 23 23 23
Total Reserves 2419.3 2096 2202.6 1252.8 992.5
Borrowings 0 0 0 0 0
Other N/C liabilities 1124.1 1280.3 1038.9 808.7 1152.9
Current liabilities 1673.5 1694.1 2289.9 2742.5 2534.7
Total Liabilities 5239.9 5093.4 5555.3 4827.9 4703.1
Assets
Net Block 498.7 464.1 334.1 305.5 314.9
Capital WIP 12.7 6.3 8.9 18.8 13.3
Intangible WIP 4.7 3.7 3.9 4.8 2.6
Investments 0 0 0 0 2
Loans & Advances 1617.2 1773.1 1521.4 877.7 1233.2
Other N/C Assets 7.2 5.6 11.8 9 7.4
Current Assets 3099.4 2840.6 3675.2 3612.1 3129.7
Total Assets 5239.9 5093.4 5555.3 4827.9 4703.1
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023
Profit from operations 599.9 677.2 1257.6 864.3 845.8
Adjustment 78.4 65 -482 -159.3 -24.8
Changes in Assets & Liabilities -37.7 62.2 68.1 -45.6 -348.9
Tax Paid -228.3 -193.3 -284.9 -260.7 -241.3
Operating Cash Flow 412.3 611.1 558.8 398.7 230.8
Investing Cash Flow 65.7 276.4 630.8 650.9 35.5
Financing Cash Flow -183.2 -810 -849 -1582.7 -878.3
Net Cash Flow 294.8 77.5 340.6 -533.1 -612

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 60.40 60.40 60.40 60.40 60.40
hoechst gmbh 60.37 60.37 60.37 60.37 60.37
sanofi 0.02 0.02 0.02 0.02 0.02
PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
investors 39.60 39.60 39.60 39.60 39.60
aditya birla sun life tru... 2.62 3.68 3.79 3.25 2.63
bajaj allianz life insura... - 1.68 1.75 1.60 1.56
general insurance corpora... - 1.43 1.43 1.43 1.58
hdfc life insurance compa... 1.92 - - - 1.45
investor education and pr... - - - - 0.19
life insurance corporatio... 5.95 - - - 5.95
llp 0.02 0.02 0.02 0.05 0.04
nippon life india trustee... 3.41 3.83 3.92 3.90 3.87
sbi magnum midcap fund - - - - 3.10
hdfc life insurance compa... - 1.26 1.39 1.39 -
investor education and pr... 0.18 0.19 0.19 0.19 -
life insurance corporatio... - 5.95 5.95 5.95 -
sbi contra fund 1.79 1.79 1.80 1.80 -
bajaj allianz life insura... 1.65 - - - -
general insurance coporat... 1.53 - - - -

Annual Reports

Ratings & Research Reports

Company Presentations

Company News

Sanofi India - Quaterly Results 7 Nov, 6:02 PM Sanofi India - Quaterly Results 7 Nov, 6:02 PM Sanofi India - Quaterly Results 7 Nov, 6:02 PM Sanofi India informs about details of loss of certificate 1 Aug, 2:53 PM Sanofi India - Quaterly Results 26 Jul, 3:32 PM Sanofi India - Quaterly Results 26 Jul, 3:32 PM Sanofi India - Quaterly Results 26 Jul, 3:32 PM Sanofi India informs about change in management 24 Jun, 4:20 PM Sanofi India - Quaterly Results 13 May, 7:03 PM Sanofi India - Quaterly Results 13 May, 7:03 PM Sanofi India enters into partnership with Cipla 27 Mar, 11:42 AM Sanofi India informs about loss of share certificate 12 Mar, 5:20 PM Sanofi India informs about loss of share certificates 11 Mar, 12:12 PM Sanofi India informs about outcome of analyst meet 26 Feb, 5:15 PM Sanofi India - Quaterly Results 23 Feb, 6:08 PM Sanofi India - Quaterly Results 23 Feb, 6:08 PM Sanofi India - Quaterly Results 23 Feb, 6:08 PM Sanofi India informs about newspaper publication 20 Feb, 4:37 PM Sanofi India informs about loss of share certificates 1 Feb, 12:03 PM Sanofi India informs about newspaper publication 16 Jan, 5:13 PM Sanofi India informs about disclosure 29 Nov, 12:29 PM Sanofi India - Quaterly Results 8 Nov, 5:35 PM Sanofi India - Quaterly Results 8 Nov, 5:35 PM Sanofi India submits board meeting intimation 19 Oct, 4:49 PM Sanofi India informs about change in management 17 Oct, 12:40 PM Sanofi India informs about investor awareness on ODR mechanism 23 Sep, 4:22 PM Sanofi India informs about issuance of duplicate share certificates 22 Aug, 2:30 PM Sanofi India - Quaterly Results 10 Aug, 3:56 PM Sanofi India - Quaterly Results 10 Aug, 3:56 PM Sanofi India - Quaterly Results 10 Aug, 3:56 PM Sanofi India informs about board meeting 26 Jul, 2:40 PM Sanofi India informs about resignation of non-executive director 20 Jul, 12:36 PM Sanofi India informs about issuance of duplicate share certificates 19 Jul, 4:46 PM Sanofi India informs about closure of trading window 22 Jun, 1:27 PM Sanofi India informs about details of loss of certificate 19 Jun, 4:59 PM Sanofi India informs about minutes of 67th AGM 31 May, 4:40 PM Sanofi India informs about newspaper publication 29 May, 12:22 PM Sanofi India gets nod to demerge consumer healthcare business into separate entity 10 May, 5:00 PM Sanofi India - Quaterly Results 10 May, 2:10 PM Sanofi India - Quaterly Results 10 May, 2:10 PM Sanofi India - Quaterly Results 10 May, 2:10 PM Sanofi India informs about details of loss of certificate 3 Apr, 5:18 PM Sanofi India informs about loss of share certificate 23 Mar, 4:01 PM Sanofi India informs about newspaper publication 27 Feb, 3:55 PM Sanofi India - Quaterly Results 23 Feb, 5:13 PM Sanofi India - Quaterly Results 23 Feb, 5:13 PM Sanofi India - Quaterly Results 23 Feb, 5:13 PM Sanofi India informs about details of loss of certificate 18 Feb, 11:51 AM Sanofi India informs about loss of share certificates 6 Feb, 1:12 PM Sanofi India informs about certificate 27 Jan, 12:49 PM

Sanofi India Stock Price Analysis and Quick Research Report. Is Sanofi India an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Sanofi India and its performance over the period of time. Sanofi India stock price today is Rs 6054.05.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Sanofi India cash from the operating activity was Rs 230.8 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Sanofi India has a Debt to Equity ratio of 0 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Sanofi India , the EPS growth was -2.8037 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Sanofi India has OPM of 28.157553225071 % which is a good sign for profitability.
     
  • ROE: Sanofi India have a healthy ROE of 55.8312 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Sanofi India is Rs 6054.05. One can use valuation calculators of ticker to know if Sanofi India share price is undervalued or overvalued.
Last Updated on:
Brief about Sanofi India

Sanofi India Ltd Financials: Check Share price, Balance Sheet, Annual report and Quarterly Results for company analysis 

Sanofi India Ltd Share Price

 

Sanofi India Ltd. is a pharmaceutical company operating in India. In this section, we will analyze the share price performance of Sanofi India Ltd. Ticker pre-built screening tools provide investors with real-time updates on the share price movements of the company.

Sanofi India Ltd Balance Sheet

Analyzing the balance sheet of Sanofi India Ltd. is crucial for long-term stock investors. It helps in understanding the financial position of the company. However, we do not provide specific financial data points about the stock. You can access the balance sheet of Sanofi India Ltd. on Ticker for a comprehensive analysis.

Sanofi India Ltd Annual Report

The annual report of Sanofi India Ltd. is a valuable resource for investors looking to analyze the company's performance over the years. You can download the annual report from Ticker to gain insights into the company's operations, financials, and future prospects.

Sanofi India Ltd Dividend

Investors seeking long-term investment opportunities often consider dividends as an important factor. Sanofi India Ltd. has a track record of consistent dividend payments. You can find more information about the dividend history and yield of Sanofi India Ltd. on Ticker.

Sanofi India Ltd Quarterly Result

Analyzing the quarterly results of Sanofi India Ltd. provides investors with the latest information on the company's financial performance. Ticker offers downloadable quarterly results, allowing investors to stay updated with the latest developments and make informed decisions.

Sanofi India Ltd Stock Price

Tracking the stock price of Sanofi India Ltd. is essential for investors. Ticker provides real-time stock price information, enabling investors to monitor fluctuations and make timely investment decisions. You can also access historical price charts to analyze the stock's performance over time.

Sanofi India Ltd Price Chart

The price chart of Sanofi India Ltd. shows the historical performance of the stock. By visually analyzing the price movements, investors can identify patterns and trends that may guide their investment decisions. You can access the price chart on Ticker for a comprehensive stock analysis.

Sanofi India Ltd News

Staying updated with the latest news and developments related to Sanofi India Ltd. is crucial for investors. Ticker provides a dedicated news section where you can find the latest updates, market trends, and announcements regarding Sanofi India Ltd.

Sanofi India Ltd Concall Transcripts

Concall transcripts provide valuable insights into the company's performance and management's outlook. At Ticker, you can access the concall transcripts of Sanofi India Ltd., allowing investors to understand the discussions held during the conference calls and gain deeper insights into the company's strategies.

Sanofi India Ltd Investor Presentations

Investor presentations offer an in-depth understanding of Sanofi India Ltd.'s business strategies, financials, and future prospects. Ticker provides access to investor presentations, enabling investors to make informed investment decisions based on comprehensive information.

Sanofi India Ltd Promoters

Understanding the promoters of a company is crucial for investors. The promoters of Sanofi India Ltd. play a significant role in the company's operations and decision-making. You can find information about the promoters of Sanofi India Ltd. on Ticker.

Sanofi India Ltd Shareholders

Analyzing the shareholder structure of Sanofi India Ltd. provides insights into the ownership pattern and the distribution of shares. Ticker offers details on the major shareholders of Sanofi India Ltd., helping investors understand the dynamics of ownership within the company.

Sanofi India Ltd ROCE

Sanofi India Ltd's Return on Capital Employed (ROCE) is a crucial financial metric that measures the company's profitability and efficiency in utilizing capital investments. Our stock analysis page provides comprehensive ROCE data for Sanofi India Ltd, allowing investors to evaluate the company's ability to generate returns from the capital employed. By analyzing this ratio, investors can gain insights into the company’s financial performance. Access the detailed ROCE information for Sanofi India Ltd in the financials table or ratio section on this page.

Sanofi India Ltd EBITDA

Sanofi India Ltd's Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is a key measure for assessing the company's operational performance and profitability. Our stock analysis page provides comprehensive EBITDA data for Sanofi India Ltd, enabling investors to evaluate the company's core earnings and financial health. Access the detailed EBITDA figures for Sanofi India Ltd in the financials table or ratio section on this page.

Sanofi India Ltd DPS

Sanofi India Ltd's Dividends Per Share (DPS) reflect the portion of profits distributed to shareholders as dividends. Monitoring DPS is crucial for investors seeking a consistent income from dividends. Our stock analysis page features the DPS data for Sanofi India Ltd, enabling investors to track the company's dividend history and payout ratio. Access the detailed DPS information for Sanofi India Ltd in the financials table or ratio section on this page.

Sanofi India Ltd EPS

Earnings Per Share (EPS) is a fundamental financial metric that measures Sanofi India Ltd's profitability on a per-share basis. Our stock analysis page provides detailed EPS information for Sanofi India Ltd, allowing investors to evaluate the company's earnings performance and growth potential. Access the comprehensive EPS figures for Sanofi India Ltd in the financials table or ratio section on this page to make informed investment decisions.

Read More
X